Delivery Order SPE2DE21D7010-SPE2D626F13DG
- Not listed
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and services, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on May 8, 2025. This fixed-price delivery order with economic price adjustment mechanism carries an ultimate completion date of May 9, 2025, and is not associated with any set-aside designation, indicating open market competition. The contract supports the federal healthcare system's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $9,642.60 by the Defense Logistics Agency Medical Supply Chain on December 11, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting successful competition in an open market procurement. The award is scheduled for completion by January 2, 2026, with...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $31,501.86 delivery order (Contract No. 4570253545) by the Defense Logistics Agency Medical Supply Chain on December 11, 2025, with an ultimate completion date of January 2, 2026. The contract, issued without set-aside designation, is structured as a fixed-price delivery order with economic price adjustment mechanisms and covers the RELINE-ONE spinal implant product line....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $43,480.80 fixed-price delivery order with economic price adjustment provisions by the Defense Logistics Agency Medical Supply Chain on October 28, 2025, with an ultimate completion date of November 18, 2025. The award is designated as an M5 delivery order issued without set-aside restrictions, indicating competition in an open market procurement. Performance will be...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $55,910.77 on December 11, 2025, for reline open implants under contract 4570278357. This fixed-price delivery order with economic price adjustment mechanisms is funded through the Defense Logistics Agency Medical Supply Chain, which procures medical supplies and equipment for Department of Defense and Department of Veterans Affairs healthcare...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $19,285.20 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 22, 2025. This delivery order, designated M5, represents a competitive procurement with no set-aside restrictions and falls under the company's established relationship with the Defense...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $2,438.82 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, for ultimate completion by December 11, 2025. This delivery order, designated as contract M5, carries no set-aside restrictions and represents an open market procurement. The award funds the supply of...
- Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a delivery order valued at $10,273.52 on January 2, 2026, for the supply of SMALL INTERLOCK II spinal implants. This fixed-price delivery order with economic price adjustment mechanisms is funded through the Defense Logistics Agency Medical Supply Chain, which procures medical supplies and equipment for Department of Defense and Department of Veterans Affairs healthcare facilities. The contract carries no set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,839.63 for allograft products on November 25, 2025, with an ultimate completion date of December 23, 2025. This fixed-price contract with economic price adjustment was funded by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical supplies and equipment...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,956.60 on December 12, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by January 6, 2026, and involves the supply of MAXCESS spinal surgical products and related medical devices to support federal...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F13DGDelivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a fixed-price delivery order valued at $13,162.05 by the Defense Logistics Agency Medical Supply Chain on January 16, 2026, with an ultimate completion date of February 6, 2026. This delivery order, classified as contract number 4570562058 for M5 spinal implant products, carries an economic price adjustment mechanism and was awarded without set-aside restrictions through open market competition. The work will be performed at Nuvasive's facility in San Diego, California. This delivery order is issued under the broader $8 million Blanket Purchase Agreement (Indefinite Delivery/Indefinite Quantity contract) that Transplant Technology Inc. maintains with the Defense Health Agency through March 2027. Nuvasive specializes in advanced spinal surgery products and services, including spinal fusion devices, interbody implants, bone graft materials, and surgical instruments that support complex orthopedic and neurosurgical procedures across Department of Defense and Department of Veterans Affairs medical facilities. The company's sustained portfolio of federal contracts demonstrates its critical role as a supplier of specialized medical technologies that directly support the operational readiness and medical mission effectiveness of military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 1/15/26 |